Search
Now showing items 1-1 of 1
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
(2018-02)
Patient-derived organoids (PDOs) have recently emerged as robust preclinical models; however, their potential to predict clinical outcomes in patients has remained unclear. We report on a living biobank of PDOs from ...